分析法和杂质

Traditional biologics, new biotherapeutics modalities and biosimilars are flooding discovery and development pipelines. Thus, analytical function is rapidly evolving, demanding high-throughput and high-resolution tools, focused biomolecular and biophysical assays, and rapid analytical and impurity profiling strategies. The Analytics & Impurities pipeline features in-depth perspectives on the latest developments and most critical steps in characterization of biologics, stability issues arising from particles, impurities, immunogenicity, protein aggregates and their impact on stability and safety of biopharmaceuticals.


1月20~21日

Characterization of Biotherapeutics
( 生物学制剂表征 )

1月21~22日

Detection and Characterization of Particulates and Impurities
( 微粒和杂质的检测和表征 )

1月23~24日

Protein Aggregation and Emerging Analytical Tools
( 蛋白质聚集和新分析工具 )


Keynote Speakers

Elizabeth M. Topp, PhD, Dane O. Kildsig Chair and Department Head, Department of Industrial and Physical Pharmacy, Purdue University


Paolo Arosio, PhD, Professor, Biochemical Engineering, Department of Chemistry and Applied Biosciences, ETH Zurich


Peter Schurtenberger, PhD, Professor, Department of Chemistry, Lund University



* 活动内容有可能不事先告知作更动及调整。

Choose your language
Chinese
Japanese
Korean
English






2020年会议节目和培训研讨会


免费电子邮件通知服务